by ZPHC
Retatrutide 20mg kit (5×4mg) by ZPHC. GIP/GLP-1/Glucagon triple agonist.
In stock
Pay with Bitcoin or USDT (TRC-20) on this site, or contact a representative for a card or bank payment link. Free EU shipping over €250.
Batch certificate of analysis available on request via Telegram or the contact form.
ZPHC Retatrutide 20mg kit contains five 4mg lyophilized vials of retatrutide with bacteriostatic water. At this dose range, clinical data show consistent metabolic improvements including significant reductions in BMI, waist circumference and lipid profiles in research models. For laboratory research use only.
Weight Loss & GLP-1
GLP-1 receptor agonist research is evolving rapidly beyond injectable semaglutide: oral formulations, triple agonists (GLP-1/GIP/glucagon), CNS-targeted analogs, and organ-protective applications. Research guide to the next-generation GLP-1 pipeline and the mechanistic frontiers being explored in 2025–2026.
6 min read
Peptides & Recovery
GLP-1 receptor agonists improve insulin resistance through multiple mechanisms beyond GLP-1R signaling — including hepatic gluconeogenesis suppression, adipose tissue remodeling, and GIP receptor co-stimulation. Advanced research guide to GLP-1 insulin sensitization pathways and experimental models.
5 min read
Weight Loss & GLP-1
Semaglutide, retatrutide, and tirzepatide represent three generations of incretin-based therapy with distinct receptor targets. Research comparison of mechanisms, clinical trial weight loss data, receptor pharmacology, and research applications for each compound class.
4 min read
Research use only. All products are sold strictly for in-vitro and laboratory research. Not for human consumption, veterinary use, diagnosis, treatment or prevention of any disease. Must be handled by qualified professionals in a controlled laboratory setting. JuicedPharma makes no therapeutic or medical claims about this compound.
Hilma Biocare
Triple GIP/GLP-1/Glucagon agonist. Next-generation metabolic research compound.
98.5%· Janoshik
ZPHC
Retatrutide 10mg (5×2mg) lyophilized by ZPHC. Triple GIP/GLP-1/Glucagon agonist.
99%+· ZPHC
ZPHC
Retatrutide 15mg single vial by ZPHC. Starter dose for triple agonist research.
99%+· ZPHC
ZPHC
Retatrutide 30mg premixed AQ auto-injector pen by ZPHC. Ready-to-use.
99%+· ZPHC
Resellers, laboratories and publishers: apply for partner pricing, volume terms and a dedicated representative.
Research use only. All products are sold strictly for in-vitro and laboratory research. Not for human consumption, veterinary use, diagnosis, treatment or prevention of any disease. Products sold by JuicedPharma are not medicines. By ordering you confirm you are a qualified person buying for research in compliance with applicable regulations. Full disclaimer